Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults

Summary

Two randomized, placebo-controlled, double-blind ascending-dose studies evaluated single and repeated subcutaneous CJC-1295 in healthy adults.

Limitations

Healthy volunteers, short follow-up and biomarker endpoints limit conclusions about therapeutic benefit and long-term safety.

Linked peptides

• CJC-1295